Literature DB >> 26220983

Chikungunya fever presenting with acute optic neuropathy.

Abhijit Anand Mohite1, Adriana Agius-Fernandez1.   

Abstract

Chikungunya fever is a vector borne virus that typically causes a self-limiting systemic illness with fever, skin rash and joint aches 2 weeks after infection. We present the case of a 69-year-old woman presenting with an acute unilateral optic neuropathy as a delayed complication of Chikungunya virus (CHIKV) infection contracted during a recent trip to the West Indies. She presented to our ophthalmology department with acute painless visual field loss in the right eye and a recent flu-like illness. She was found to have a right relative afferent pupillary defect (RAPD) with unilateral optic disc swelling. Serology confirmed recent CHIKV infection. Treatment with intravenous methylprednisolone was delayed while awaiting MRI scans and serology results. At 5-month follow-up, there was a persistent right RAPD and marked optic atrophy with a corresponding inferior scotoma in the visual field. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26220983      PMCID: PMC4521522          DOI: 10.1136/bcr-2015-210081

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Mild Guillain-Barré syndrome.

Authors:  D M Green; A H Ropper
Journal:  Arch Neurol       Date:  2001-07

2.  Bilateral macular choroiditis following Chikungunya virus infection.

Authors:  B Chanana; R V Azad; S Nair
Journal:  Eye (Lond)       Date:  2007-05-04       Impact factor: 3.775

3.  Chikungunya virus: the neurology.

Authors:  Jmk Murthy
Journal:  Neurol India       Date:  2009 Mar-Apr       Impact factor: 2.117

4.  Death due to chikungunya.

Authors:  Bhaswati Bandyopadhyay; Debasish Bandyopadhyay; Rana Bhattacharya; Rajyasree De; Bibhuti Saha; H Mukherjee; A K Hati
Journal:  Trop Doct       Date:  2009-07       Impact factor: 0.731

5.  Optic neuritis associated with chikungunya virus infection in South India.

Authors:  Apoorva Mittal; Saurabh Mittal; M Jayahar Bharati; Rengappa Ramakrishnan; Sankarlingam Saravanan; Padmakar S Sathe
Journal:  Arch Ophthalmol       Date:  2007-10

Review 6.  Chikungunya: an overview.

Authors:  A B Sudeep; D Parashar
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

7.  Ocular involvement associated with an epidemic outbreak of chikungunya virus infection.

Authors:  Prajna Lalitha; Sivakumar Rathinam; Krishnadas Banushree; Shanmugam Maheshkumar; Rajendran Vijayakumar; Padmakar Sathe
Journal:  Am J Ophthalmol       Date:  2007-08-09       Impact factor: 5.258

8.  Ocular manifestations associated with chikungunya.

Authors:  Padmamalini Mahendradas; Shylaja K Ranganna; Rohit Shetty; Ramgopal Balu; Kannan M Narayana; Rajesh B Babu; Bhujang K Shetty
Journal:  Ophthalmology       Date:  2007-07-12       Impact factor: 12.079

9.  Treatment guidelines for Guillain-Barré Syndrome.

Authors:  A K Meena; S V Khadilkar; J M K Murthy
Journal:  Ann Indian Acad Neurol       Date:  2011-07       Impact factor: 1.383

10.  Novel chikungunya virus variant in travelers returning from Indian Ocean islands.

Authors:  Philippe Parola; Xavier de Lamballerie; Jacques Jourdan; Clarisse Rovery; Véronique Vaillant; Philippe Minodier; Philippe Brouqui; Antoine Flahault; Didier Raoult; Rémi N Charrel
Journal:  Emerg Infect Dis       Date:  2006-10       Impact factor: 6.883

View more
  4 in total

Review 1.  The Range of Neurological Complications in Chikungunya Fever.

Authors:  T Cerny; M Schwarz; U Schwarz; J Lemant; P Gérardin; E Keller
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

Review 2.  Neurologic Manifestation of Chikungunya Virus.

Authors:  Kate Brizzi
Journal:  Curr Infect Dis Rep       Date:  2017-02       Impact factor: 3.663

3.  Recurrent chikungunya retinitis.

Authors:  Silvia Olivia Salceanu; Vasant Raman
Journal:  BMJ Case Rep       Date:  2018-08-27

4.  Isolated facial palsy after Chikungunya infection: A novel differential diagnosis

Authors:  Augusto Peñaranda; Daniel Peñaranda; María M Gantiva-Navarro; Lucía C Pérez-Herrera
Journal:  Biomedica       Date:  2022-09-02       Impact factor: 1.173

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.